💊 Gliclazide
Gliclazide Tablets BP 80 mg are used to treat maturity onset diabetes mellitus. They work mainly by enhancing the release of the body's own insulin from the pancreas. The dose is set by your doctor or pharmacist for each patient.
In Arabic: جليكلازيد✅ What it is used for
- Treatment of maturity onset diabetes mellitus
🧪 Active ingredient
Each tablet contains gliclazide 80 mg. It acts primarily by enhancing the release of endogenous insulin from pancreatic B cells, so some residual B-cell function is necessary for it to work. At normal therapeutic doses it also reduces platelet adhesiveness and aggregation.
🌿 Benefits
- Lowers blood glucose in maturity onset diabetes mellitus
- Evidence indicates it is effective and well tolerated in elderly patients
📝 How to use
- The tablets are taken by mouth.
- The dose is set and adjusted by your doctor or pharmacist according to your response; do not change it yourself.
- When higher doses are required, a twice-daily split dose is advised, divided according to the main meals of the day.
- Taking the tablets with meals may help avoid mild gastro-intestinal disturbances.
💊 Dosage forms
- Tablets 80 mg
- Blister packs of 7, 10, 28, 30, 56, 60, 100, 120 and 250 tablets
⚠️ Common side effects
- Hypoglycaemia (low blood sugar)
- Mild gastro-intestinal disturbances such as nausea, dyspepsia, diarrhoea and constipation
- Abnormal liver function (not uncommon)
🚨 Serious — seek medical help
- Moderate or severe hypoglycaemia (which may involve coma or neurological impairment)
- Hypersensitivity reactions that may be severe: skin reactions (rash, pruritus, erythema, bullous eruption), with rare progression to erythema multiforme and exfoliative dermatitis
- Rare reports of hepatic failure, hepatitis and jaundice
- Rare blood disorders: aplastic anaemia, haemolytic anaemia, leucopenia, thrombocytopenia, granulocytopenia
- Cholestatic jaundice and fever (rare)
⛔ Do not use if
- Juvenile onset diabetes
- Diabetes complicated by ketosis and acidosis
- Porphyria
- Pregnancy and breast feeding
- Diabetics undergoing surgery, after severe trauma or during infections
- Known hypersensitivity to gliclazide or chemically related drugs (including other sulphonylureas)
- Diabetic pre-coma and coma
- Severe renal or hepatic insufficiency
❗ Warnings & precautions
- Care should be exercised in patients with hepatic and/or renal impairment, using a small starting dose with careful monitoring.
- Hypoglycaemia will occur if dietary intake is reduced or if a higher dose than required is taken.
- Risk of hypoglycaemia is greater in patients controlled by diet alone, in overdose, when calorie or glucose intake is insufficient, and in hepatic and/or renal impairment.
- Mild hypoglycaemia symptoms (sweating, pallor, hunger, tachycardia, malaise) should be treated with oral glucose, with dose or meal-pattern adjustments made by the doctor.
- Loss of glucose control may occur with stress such as fever, trauma, infection or surgery; the doctor may need to increase the dose or switch to insulin.
- Caution in G6PD-deficiency: sulphonylureas can cause haemolytic anaemia, and a non-sulphonylurea alternative should be considered.
- Ability to concentrate may be affected if diabetes control is unsatisfactory, particularly at the start of treatment, so take care when driving or using machines.
- Additional therapy should be considered in obese patients or those not responding adequately to gliclazide alone.
🔄 Drug interactions
- May increase the hypoglycaemic effect: phenylbutazone, salicylates, sulphonamides, coumarin derivatives, MAOIs, beta-blocking agents, tetracycline compounds, chloramphenicol, clofibrate, disopyramide, miconazole (oral forms), cimetidine and alcohol.
- May diminish the hypoglycaemic effect: corticosteroids, oral contraceptives, thiazide diuretics, phenothiazine derivatives, thyroid hormones and laxative abuse.
- Tell your doctor or pharmacist about all medicines you are taking.
🤰 Pregnancy
Gliclazide should not be used in pregnancy. In animals it crossed the placental barrier and penetrated the foetus.
🍼 Breastfeeding
Should not be used during breast feeding. It is not known whether gliclazide is excreted in milk, but other sulphonylureas have been detected in milk and there is no evidence that gliclazide differs in this respect.
🧒 Children
Gliclazide, as with other sulphonylureas, is not indicated for the treatment of juvenile onset diabetes mellitus.
👴 Older adults
Plasma clearance of gliclazide is not altered in the elderly, and it is effective and well tolerated. Care should still be exercised when prescribing sulphonylureas in the elderly due to a possible age-related increased tendency for hypoglycaemia.
🌡️ Storage
Store at or below 25°C. Shelf life is 3 years. There are no special handling instructions for disposal.
⏰ Missed dose
The official SPC gives no instructions on missed doses; ask your doctor or pharmacist.
🆘 Overdose
The symptom expected in overdose is hypoglycaemia. Treatment is gastric lavage and correction of the hypoglycaemia by appropriate means with continued monitoring of blood sugar. Seek medical help immediately if overdose is suspected.
💰 Price & brands in your area
Local prices are currently available for Palestine; more countries are coming. Ask your pharmacist for local price and alternatives.
📍 Find the nearest pharmacy
Your location is used only in your browser to show nearby pharmacies — we don't store it.
Open in Google Maps👨⚕️ For healthcare professionals
Mechanism of action
Enhances release of endogenous insulin; believed to involve degranulation of pancreatic B cells associated with increased insulin secretion, and requires residual B-cell function. Reduces platelet adhesiveness and aggregation at therapeutic doses. Readily absorbed from the GI tract, half-life approximately 10–12 hours, strongly bound to plasma proteins, extensively metabolised in the liver to metabolites without significant hypoglycaemic activity; unchanged drug and metabolites are excreted in urine.
Labeled dosing
Adults: total daily dose 40–320 mg orally, adjusted to response, commencing with 40–80 mg daily (½–1 tablet) and increasing until adequate control is achieved. A single dose should not exceed 160 mg (2 tablets); when higher doses are required, a twice-daily split dosage divided according to the main meals is advised. The final dose is determined by the doctor/pharmacist.
- In obese patients or those with inadequate response to gliclazide alone, consider additional therapy.
- Commence treatment of non-insulin-dependent diabetics by diet alone if possible, take patient age into account, and adjust dosage according to blood glucose and 24 h urinary glucose in the first few days.
- Hepatic/renal impairment: small starting dose and careful monitoring; long-term trials in renal insufficiency showed satisfactory treatment at reduced doses.
- During stress (fever, trauma, infection, surgery) progressive dose increase may be needed; if response is insufficient consider discontinuing gliclazide and giving insulin.
- G6PD-deficiency: risk of haemolytic anaemia; consider a non-sulphonylurea alternative.
🎓 Key points for students
- Gliclazide is a sulphonylurea hypoglycaemic agent that stimulates insulin release from pancreatic B cells.
- It requires residual B-cell function to be effective.
- Key adverse effect is hypoglycaemia, especially with reduced intake, overdose, hepatic/renal impairment, or in the elderly.
- Contraindications include juvenile onset diabetes, ketoacidosis, porphyria, pregnancy, breast feeding and severe renal/hepatic insufficiency.
- Interactions: potentiated by e.g. salicylates, beta-blockers and alcohol; diminished by e.g. corticosteroids and thiazide diuretics.
- Half-life about 10–12 hours; hepatic metabolism, urinary excretion.
EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.
Try EME free How we protect your data❓ FAQ
What are gliclazide tablets used for?
They are used to treat maturity onset diabetes mellitus by enhancing the release of insulin from the pancreas.
What is the most important side effect of gliclazide?
Hypoglycaemia (low blood sugar), which can be moderate or severe. Mild symptoms include sweating, pallor, hunger, fast heartbeat and malaise; they are treated with oral glucose and medical review.
Can gliclazide be used in pregnancy or breast feeding?
No. It should not be used during pregnancy or breast feeding.
Can I drink alcohol while taking gliclazide?
Alcohol may increase the blood-sugar-lowering effect of gliclazide, so ask your doctor or pharmacist.
How can stomach upset be reduced?
Taking gliclazide with meals may help avoid mild gastro-intestinal effects such as nausea and dyspepsia.
Can I change my dose myself?
No. Your doctor or pharmacist sets and adjusts the dose according to your response and blood glucose.
⚕️ For education only — not a substitute for your doctor or pharmacist, who make the decision. Source: official UK MHRA Summary of Product Characteristics — GLICLAZIDE TABLETS BP 80MG (2026-05-15)